Cryptococcosis

Özet

  • An invasive opportunistic fungal infection predominantly seen in immunocompromised patients, although immunocompetent hosts may also be affected.
  • The lungs are generally the primary locus of infection, with extrapulmonary dissemination affecting the meninges and, less commonly, the skin, bones, prostate, and other organs.
  • Microbiology, serum antigen levels, and histopathology are required to make the diagnosis.
  • Meningoencephalitis is life-threatening, particularly in immunosuppressed patients.
  • Unrecognised and untreated cryptococcosis can be fatal, especially in immunocompromised patients.
  • Treatment depends on the immunological state and disease severity. For asymptomatic and mild to moderate disease with no central nervous system (CNS) involvement, oral fluconazole is the first-line treatment. Amphotericin induction followed by a course of fluconazole is recommended for severe disease and CNS involvement.
  • Primary prophylaxis with either itraconazole or fluconazole is effective in reducing the incidence of cryptococcal disease in adults with HIV (CD4 <100 cells/microlitre), but there is no clear effect on overall mortality.
Son güncellenme: Kas 22, 2012
Top

Use of this content is subject to our disclaimer